NEW YORK/LONDON, Jan 20 (Reuters) – Top advertisers on Twitter cut spending after the Elon Musk takeover, according to estimates compiled for Reuters by research firm Pathmatics, in the latest shock to the top source. of business income. According to Pathmatics estimates, fourteen of the top 30 advertisers on Twitter ceased all advertising on the …
Here’s what Twitter lost in ad revenue in the final months of 2022 Read More »
DAVOS, Switzerland, Jan 19 (Reuters) – In the snow and ice on the main street of Davos, the impact of the crypto winter is evident for WEF attendees. Last May, the dressed storefronts that line both sides of Promenade Street that runs through the Swiss ski resort were dominated by crypto companies, rolling in bitcoin. …
Davos 2023: Intimidated Crypto Crowd Feels Winter Freeze at WEF Read More »
DAVOS, Switzerland, Jan 18 (Reuters) – Microsoft Corp (MSFT.O) said on Wednesday it would cut 10,000 jobs and take a $1.2 billion charge from profits as its cloud computing customers reassess their expenses and that the company prepares for a possible recession. . The layoffs add to the tens of thousands announced in recent months …
Microsoft to cut 10,000 jobs, adding to tech layoff glut Read More »
CHICAGO, Dec 13 (Reuters) – An experimental cancer vaccine from Moderna Inc (MRNA.O) based on messenger RNA (MRNA) technology used in successful COVID-19 vaccines has been shown to be effective against melanoma , sending Moderna shares more than 20% higher and pushing other biotechs working on similar treatments soaring. A combination of Moderna’s personalized cancer …
Positive Moderna, Merck Cancer Vaccine Data Advances mRNA Promise, Stocks Rise Read More »
LONDON, Dec 5 (Reuters) – Pension funds and other “non-bank” financial firms hold more than $80 trillion in hidden off-balance sheet dollar debt in foreign exchange swaps, the Bank for International Settlements (BIS) said. ). The BIS, dubbed the central bank of central banks around the world, also said in its latest quarterly report that …
Currency swap debt is an $80 trillion global regulator, says ‘blind spot’ Read More »
Trials show small benefit, but without statistical validity Roche setback leaves Biogen and Eisai as leaders in the field It’s up to Roche’s CEO-designate to revive development fortunes Roche shares down 3.4%, its development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) Alzheimer’s drug candidate has not been shown to slow the progression …
Roche’s Alzheimer’s drug fails in long-awaited trial Read More »
LONDON, Oct 25 (Reuters) – European stocks were mixed on Tuesday and U.S. futures pointed to a weaker open for Wall Street as investors hoped the Federal Reserve could slow its rate hikes gave way to a more cautious tone in front of the American earnings company. Asian stocks struggled to make gains on uncertainty …
Wall Street expected to open lower ahead of earnings Read More »
